Source: International Congress 2014 – Acute pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. M. Koo, Y. K. Kim, S. T. Uh, K. U. Kim (Seoul, Republic Of Korea). Warfarin-associated intracranial hemorrhage during anticoagulation therapy. Eur Respir J 2014; 44: Suppl. 58, 2401

Member's Comments

No comment yet.

Related content which might interest you: Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Outcomes in embolisations of pulmonary arterio-venous malformations Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Do persistent perfusion defects predict late recurrences in pulmonary embolism? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Risk stratification in submassive pulmonary embolism via alveolar-arterial oxygen gradient Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Alteration of factors associated with coagulation in provoked pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Isolated hypocapnia: A sign not to be neglected Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Comparision of catheter-directed therapy with the systemic thrombolysis for the treatment of acute pulmonary embolism with right ventricular dysfunction Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Long-term screening for pulmonary hypertension after pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 An overview of thrombolytic treatment for pulmonary embolism: A single center experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Clinical phenotypes in pulmonary emboli identified by cluster analysis Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Cerebral tissue oxygenation in arterial and thromboembolic pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Early screening for reperfusionand CTEPH after acute pulmonary embolism – Early screening for reperfusion and CTEPH after acutepulmonary embolism Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Endothelial-to-mesenchymal transition in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Association between antiphospholipid antibody type and level and pulmonary manifestations in APS Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Epoprostenol dosing by concomitant therapies in the PROSPECT registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Pulmonary arterial hypertension – A single-centre experience Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014